The Vascular Endothelial Growth Factor Receptor (VEGFR) and Cancer
Abstract
Cancer continues to maintain its importance as a pathological event whose incidence continues to increase. Since the source of pathophysiology is multifaceted, it is one of the popular topics that pharmaceutical and medicinal chemists attach importance to in their studies. In recent studies, when the concept of cancer is considered, it has been observed that it is associated with the mechanism of vascular formation and the mechanisms of action of drugs. Thus, the mechanism of angiogenesis and EGF and VGF systemic pathways that play a great factor in angiogenesis have been elucidated. Inhibition of these systems was targeted while designing drugs and VEGFR (Vascular Endothelial Growth Receptors) emerged. The aim of this study is to compile the types of VEGFR, their relationship with cancer and the mechanisms of action of clinically used drugs approved by various authorities and to enable the readers of this review to recognize the specificities in targets in VEGFR inhibitor design.
Keywords
References
- Dekuang Zhao et al. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2. Oncogene, 2014; 3107-3119. https://doi.org/10.1038/onc.2014.257
- Ferrara, N. Vascular endothelial growth factor: Basic science and clinical progress. Endocrinology Reviews, 2004.
- Li, W., Wei, J., Cheng, M., & Liu, M. Unveiling promising targets in gastric cancer therapy: A comprehensive review. Molecular Therapy: Oncology, 2004; 32(32), 200857.
- Chen, Y., et al. Immunotherapy-based combination strategies for treatment of EGFR-TKI-resistant non-small-cell lung cancer. Future Medicine Ltd, 2024.
- Yang, Z., et al. Opportunities and Challenges of Nanoparticles in Digestive Tumors as Anti-Angiogenic Therapies. Frontiers in Oncology, 2024.
- Hegde, P. S., & Chen, D. S. Top 10 Challenges in Cancer Immunotherapy. Immunity, 2024.
- Li, B., Jin, J., Guo, D., Tao, Z., & Hu, X. Immune Checkpoint Inhibitors Combined with Targeted Therapy: The Recent Advances and Future Potentials. Cancers, 2023; 15(15), 2858.
- Song, Z., Tao, Y., Liu, Y., & Li, J. Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles. Frontiers in Immunology, 2024.
- Zhou, Y., et al. The Role of the VEGF Family in Coronary Heart Disease. Frontiers in Cardiovascular Medicine, 2021.
- Shah, A. A., Kamal, M. A., & Akhtar, S. Tumor Angiogenesis and VEGFR-2: Mechanism, Pathways and Current Biological Therapeutic Interventions. Current Drug Metabolism, 2022; 22(22), 50–59.